Skip to main content
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc. — Investor Relations & Filings

Ticker · VIR ISIN · US92764N1028 US Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2020-09-18 Director's Dealing
Country US United States of America
Listing US VIR

About Vir Biotechnology, Inc.

https://www.vir.bio/

Vir Biotechnology, Inc. is a clinical-stage immunology company that leverages the immune system to treat and prevent serious infectious diseases and other conditions. The company's pipeline is built on two primary technology platforms: a next-generation antibody platform for identifying and optimizing therapeutic candidates, and the PRO-XTEN® protease-releasable masking technology for applications in oncology. Vir's main therapeutic area is infectious diseases, featuring a leading program for chronic hepatitis delta, and is complemented by strategic programs in oncology. The company has demonstrated its capabilities by developing antibody-based medicines for significant health challenges, including COVID-19 and Ebola.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2020-09-18 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated September 16, 2020. It reports that Vir Biotechnology presented at the H.C. Wainwright 22nd Annual Global Investment Conference and that the presentation is attached as Exhibit 99.1. The document does not contain financial statements or detailed financial data but rather announces the event and provides the presentation as an exhibit. This fits the description of an Investor Presentation (IP) filing, as it focuses on a presentation for investors regarding the company's strategy or market position. The document length is under 5,000 characters and is primarily an announcement of the presentation, not a full report or transcript. Therefore, the appropriate classification is Investor Presentation (IP).
2020-09-16 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-10 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-10 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-03 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-03 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.